Least Developed Countries (LDCs) vs Pakistan: Percentage of bloodstream infection due to methicillin-resistant
Least Developed Countries (LDCs)
61.8%
in 2022
Pakistan
67.1%
in 2022
Least Developed Countries (LDCs) rank
1st
Pakistan rank
3rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Least Developed Countries (LDCs)
- Pakistan
How they compare
Pakistan currently reports 67.1% against 61.8% in Least Developed Countries (LDCs), a difference of 5.3%.
That makes Pakistan's figure about 1.1 times Least Developed Countries (LDCs)'s.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Pakistan ahead.
Least Developed Countries (LDCs) ranks 1st and Pakistan ranks 3rd of 15 groups.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Least Developed Countries (LDCs) | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 25.8% | 52.1% | 26.3% | Pakistan |
| 2020s | 51.6% | 73.0% | 21.4% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Least Developed Countries (LDCs) or Pakistan?
- Pakistan, at 67.1% against 61.8% in Least Developed Countries (LDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Least Developed Countries (LDCs) and Pakistan?
- 5.3%, with Pakistan ahead.
- How many years of comparable data are there for Least Developed Countries (LDCs) and Pakistan?
- 6 years are reported by both, from 2017 to 2022.
- How do Least Developed Countries (LDCs) and Pakistan rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Least Developed Countries (LDCs) ranks 1st and Pakistan ranks 3rd of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.